Rheumatoid Arthritis Flashcards

1
Q

Rheumatoid arthritis is a chronic ____ disorder of __, as well as __. There is a set pattern of __, elevated __ (2).

Pathology begins with inflammation of __, proliferation causing __ that invades bone, cartilage and ligaments leading to __ and __.

A

Chronic systemic inflammatory disorder
Joints as well as extra-articular manifestation

Joint involvement, autoantibodies (RF, ACPA)

Synovium
Pannus
Damage and deformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Model of natural pathogenesis of RA

A

Predisposing factors
1. Genetics - HLA-DR-B
2. Smoking (21 fold)
3. Bacterias and viruses
- Porphyromonos gingivalis, prevotella copri
- EBV, parvovirus B19

Preclinical RA: autoimmunity without synovitis
4. Autoantibodies: RF, ACPA

Clinical RA
5. Initiation
- Target citrullinated proteins in joints
- Immune complex deposition in synovial venules incite inflammation and complement activation
- Increased vascular permeability and influx of more inflammatory cells and antibodies
- Osteoclastogenesis, chondrocyte damage

  1. Perpetuation via adaptive immune activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Differential diagnosis of RA

A

Common
1. Seronegative spondyloarthropathies
2. CPPD
3. CTD - SLE, scleroderma, polymyositis, vasculitis, MCTD, PMR
4. Osteoarthritis
5. Viral infection (EBV, HIV, Hep B, parvovirus, rubella, Hep C)
6. Polyarticular gout
7. Fibromyalgia
8. Reactive arthritis

Uncommon
1. Hypothyroidism
2. Relapsing polychondritis
3. Subacute bacterial endocarditis
4. Rheumatic fever
5. Haemochromatosis
6. Sarcoidosis
7. Hypertrophic osteoarthropathy
8. Lyme disease
9. Hyperliproproteinaemia
10. Amyloidosis
11. Sickle cell disease
12. Malignancy and paraneoplastic
13. Behcet’s disease

Rare
1. Familial Mediterranean fever
2. Whipple’s disease
3. Multicentric reticulohistiocytosis
4. Angioimmunoblastic lymphadenopathy
5. SAPHO - synovitis, acne, pustulosis, hyperostosis and osteitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACR-EULAR 2010 Criteria for Classification of RA

A

Score of 6 or more

  1. Joint involvement
    - Large joints vs small joints
  2. Serology
    - Negative, low positive or high positive
  3. Acute phase reactants
  4. Duration of symptoms - > 6 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiology of RA

A
  1. All races, more in Native Americans
  2. Female > males (3:1)
  3. Middle age 40-60 years, prevalence increases with age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Patterns and variations of RA

A

Typical pattern
1. Insidious (65%) - onset with arthritic symptoms of pain, swelling and stiffness, increasing number of joints over weesk to months
2. Subacute (20%) - similar to insidious, but more systemic symptoms
3. Acute (10%) - severe onset, might even have fever

Atypcial pattern
4. Palindromic (episodic) - < 5 joitns, resolves with days, with recurrent flare and eventual evolvement into persistent pain and deformity
5. Insicious in elderly > 65 - severe pain and sitffness of limb girdle joints with diffuse swellling of hands, wrists, forearm. Difficult to differentiate from PMR, PS3PE
6. Arthritis robustus - in men, with bulky proliferative synovitis causing joint erosions and deformities, minimal pain or disability
7. Rheumatoid nodulosis - recurernt pain/swelling in different joints, subcutaneous nodules, subchondral bone cysts on radiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pattern and progression of RA joint involvement

What are the most/lesser commonly affected joints in RA?

What are the atypical joints to prompt alternative diagnosis?

A
  1. Small joints involvement first, then large joints
  2. Oligoarticualr onset, progressing into polyarticular and symmetrical distribution over weeks to months

Commonly affected joints
1. MCP (90-95%)
2. PIP (75-90%)
3. Wrist (75-80%)
4. Knee (60-80%)
5. Shoulder (50-70%)
6. MTP (50-60%)

Less commonly affected joints
7. Ankle/subtalar (50-60%)
8. Cervical spine (C1-C2) (40-50%)
9. Elbow (40-50%)
10. Hip (20-40%)
11. Temporomandibular (10-30%)

Atypical joints
1. Thoracolumbar - OA
2. Sacroiliac - seronegative spondyloarthritis
3. Hands DIPJ - OA, psoriatic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the clinical and laboratory findings to predict whether early undifferentiated arthritis (UA) will develop into RA?

A
  1. Higher ACR/EULAR 2010 score but not fulfilling criteria
    - 42% with score of 5 develops RA (score 6 = RA)
    - Number of involved joits, duration of symptoms, presence of autoantibodies, elevated inflammatory markers
  2. Grey scale synovitis on ultrasound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pannus is a _____
- Inflammatory infiltrates of (5) lead to organisational structure resembling __, triggering synovial lining cells to proliferate, becomes __, __ and ________
- _____ in pannus may invade __ and __ leading to __ of joint

A

Proliferative synovium

Infiltrates of: CD4+ T lymphocytes, macrophages, B cells, plasma cells, dendritic

Synovium inflamed and becomes thickened, boggy and oedematous/villous projections

Fibroblast-like synoviocytes in pannus invade bone and cartilage, leading to destruction of joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Joint deformities in RA

A

A. Hand deformities
1. Fusiform swelling over PIPJ (synovitis - spindle shaped)
2. Boutonniere deformity - flexed PIPJ, hyperextended DIPJ (extrinsic extensor tendon weakening, palmar displacement of lateral bands)
3. Swan-neck deformity - flexed MCPJ, hyperextended PIPJ, flexed DIPJ (intrinsic muscle of MCPJ contracture)
4. Ulnar defiation of fingers with radial deviation of wrist (subluxation of MCPJ, weakened ECU)
5. Z-thumb/Hitchhiker thumb - hyperextended IP, felxed MCP, adducted metacarpus, unable to pinch
6. Piano key ulnar head - floating ulnar styloid (ulnar collateral ligament destruction)

B. Feet deformity
1. MTPJ squeeze test positive - synovitis
2. Claw toe or hammer toe - MTPJ inflammation, subluxation of MT heads
3. Callus and ulcer formation
- difficulty fitting toes into shoe, tops of toes rub onto shoe box
- MT heads not cushioned, inferior surface of foot calluses
- Feels like walking on pebbles or stones
4. Pes planus and hindfoot valgus deformity - tarsal and subtalar joint involvement

C. Spinal deformity
1. C1/C2 subluxation - anterior (commonest), lateral (rotary), posterior (least common) atlantoaxial subluxation
- Widened gap between arch of C1 and odontoid of C2 (>3mm) -> ruptured transverse and alar ligament
(highest risk of compression if gap anteriorly 9mm or more, posteriorly 14mm or more)
2. C1/C2 impaction - superior migration of odontoid into foramen magnum and impinges brainstem
(Odontoid 5mm or more above Ranawat’s line)
3. Subaxial involvement of C2/C3 and C3/C4 facets and intervertebral disc (stiar stepping) - vertebrae subluxed forward on lower vertebrae 3.5mm or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Radiographic features of RA
(M: ABCDES)

What are the key differences in radiography of RA vs OA?

A

A: aligment abnormal, but no ankylosis
B: bone periarticular (juxtaarticular) osteoporosis, no periostitis or osteophytes
C: cartilage uniform/symmetric joint space loss in weight bearing joints, but no cartilage or soft tissue calcification
D: deformities - Swan neck, ulnar deviation, Boutonniere in symmetrical distribution
E: erosions marginal
S: soft tissue swelling, nodules without calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the early and late radiological progression of RA

A

Early
1. Juxtaarticular osteopenia
2. Joint erosions at margins of small joints
(hands 2/3/5 MCPs, feet 1/5 MTPs)

Late
3. Diffuse osteopenia
4. Joint space narrowing
5. Fixed deformities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Extra-articular manifetations of RA

A

A. General - fever, lymphadenopathy, weight loss, fatigue
(Only in severely active RA disease activity)

B. Dermatologic
- Palmar erythema
- Subcutaneous nodules
- Vasculitis
- Pyoderma gangrenosum

C. Ocular
- Episcleritis and scleritis -> scleral thinning -> scleromalacia perforans and corneal melt (blinding!)
- Choroid and retinal nodules
- Sicca symptoms in coexisting SS

D. Pulmonary
- Pleuritis and pleural nodules (Caplan’s syndrome)
- Interstitial lung disease and fibrosis
- Obstructive lung disease - airway thickening, bronchiolitis, bronchiectasis
- Arteritis
- Pleural effusion

E. Cardiac
- Pericarditis, myocarditis
- Coronary vasculitis
- Valve nodules

F. Neuromuscular
- Entrapment neuropathy (median, ulnar, radial)
- Peripheral neuropathy
- Mononeuritis multiplex

G. Haematologic
- Anaemia
- Felty syndrome - RA, neutropenia, splenomegaly
- Large granular lymphocyte syndrome
- Lymphomas

H. Renal - nephrotic syndrome
- Membranous GN
- Mesangioproliferative GN
- Mesangiocapillary GN
- Chronic tubulointerstitial nephritis
- Renal amyloidosis
- Tubulointerstitial nephritis, papillary necrosis, MCD (from NSAIDs)

I. Others
- Sjogren’s syndrome
- Amyloidosis
- Osteoporosis
- Atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the risk factors for extra-articular RA manifestations?

A
  1. Dual-positive RF and ACPA
    (ACPAs alone strongly associated with articular RA severity, but not strongly associated with extra-articular)
  2. HLA-DR4 positive
  3. Males
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are rheumatoid nodules?

What are the differential diagnoses to consider?

A

Subcutaneous nodules with histology of central area of fibrinoid necrosis surroundewd by zone of palisades of elongated histiocytes and peripheral layer of cellular connective tissue

Occurs in 20-35% RA patients, RF positive, severe disease
Reversible - occurs in active disease, resolves when controlled
Rarely develop paradoxical methotrexate nodulosis (usually as small, multiple nodules over finger pads)

Sites:
1. Forearm extensors
2. Olecranon bursa
3. Joints and pressure points (sacrum, occiput, heel)

Differentials
1. Xanthoma (cholesterol)
2. Gouty tophi
3. SLE (rare)
4. Amyloidosis
5. Rheumatic fever and subcutaneous nodules
6. Sarcoidosis
7. Multicentric reticulohistiocytosis
8. Leprosy
9. Granuloma annulare (no arthritis, RF neg, common in children)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

RA and joint infection risk

A

Joint infections tend to occur in:
1. Damaged joints (poorly controlled RA)
2. Immunosuppressed (ISTs)
3. Joint relpacement surgery

Common organisms
1. Staphylococcus aureus
2. CONS

17
Q

Laboratory findings in RA patients

A
  1. FBC - ACD, thrombocytosis (leukopenia in Felty)
  2. Albumin - low (negative acute phase reactant)
  3. High ESR
  4. High CRP
  5. Rheumatoid factor (RF)
  6. ACPA
  7. ANA - 30-50% positive
  8. ANCA negative (if positive - not against PR3 or MPO)
  9. Elevated C3, C4 (if low to consider other disease)
  10. Novel antibodies and inflammatory markers
18
Q

What are markers to predict RA severity and prognosis?

A
  1. Long disease duration prior to treatment
  2. RF and ACPA dual positive
  3. Poor functional status
  4. > 13 total joints involved
  5. Extra-articular disease - nodules, vasculitis
  6. Persistent elevated ESR or CRP
  7. ANA positive
  8. Rapid onset radiographic erosion within 2 years onset
  9. HLA-DR4
  10. Low education level
19
Q

Treatment goals of RA

A
  1. Treat early - within 3-6 months of synovitis onset
  2. Treat to target - low disease activity or remission
20
Q

RA disease activity

A
  1. Disease activity score in 28 joints (DAS28)
  2. Simplified disease activity index
  3. Clinical disease activity index
  4. Routine assessment of index data
21
Q

Management of RA

A

Non-pharmacological
1. PT and OT
2. Patient education

Pharmacological - DMARDs
1. Methotrexate 15-25mg/week
(30% achieve remission as monothrepy)
2. Alternative - leflunomide or azathioprine

  1. csDMARDs-MTX triple therapy
    - MTX + Sulfasalazine + Hydroxychloroquine
    (40505 cases achieve remission without toxicity)
  2. bMDARD-MTX dual therapy
    - Anti-TNF: abatacept, tocilizumab, sarilumab, rituximab, tofacitinib, baricitinib
    - Rituximab particularly helpful in both seropositive and seronegative RA
    (40-50% achieve remission on first bMDARDs)
    (if unresponsive, to switch to another agent)
22
Q

DMARDs in RA

A
23
Q

Long term prognosis of RA

What are the mortality cause in RA?

A

Historically without reatment: reduced life expectancy by 5-10 years

With aggressive DMARDs
- Reduce disability up to 30%
- Reduce joint replacement surgery need 50%
- Mortality near non-RA population

Aggressive, very early therapy
- Higher chance for prolonged disease remission
- Higher potential for cessation of therapy post-remission

Mortality in RA
1. CVS - 1.5 to 2 fold
2. Infection - 5 fold
3. Cancer and lymphoproliferative disease
- Lymphoma, leukaemia 2 to 3 fold
- Lung cancer 1.5 to 3.5 fold
- Melanoma
4. GI bleed from NSAIDs use (4$)
5. Renal disease
6. Others

24
Q

What is RS3PE syndrome?

A

Remitting seronegative symmetrical synovitis with pitting oedema

  1. Acute onset severe symmetrical synovitis of small joints of hands, wrists, flexor tendon sheath
  2. Pitting oedema of hand dorsum (boxing glove hand)
  3. Elderly (70 years) white men (male:female 4:1)
  4. RF negative
  5. Does not respond to NSAIDs, but very responsive to low dose prednisolone and hydroxychloroquine
  6. No bony erosion
  7. Does not recur after withdrawal of medication
25
Q

What are the possible causes of anaemia in RA?

A
  1. Anaemia of chronic disease/renal disease
  2. Iron deficiency and GI loss from NSAIDs use
  3. Folate deficiency from methotrexate sue
  4. Pernicious anaemia from autoimmune disease
  5. Bone marrow suppression (gold, sulfasalazine, MTX, penicillamine)
  6. Felty’s syndrome
  7. Autoimmune haemolytic anaemia